Regina Au is President, New Product Planning/Strategic Marketing Consultant at BioMarketing Insight with 20+ years experience in the biotechnology, pharmaceutical, medical device, and diagnostic industries. She helps companies to maximize the benefits of their technology upfront by conducting an in-depth business due diligence to de-risk the product development process and increase commercial success.
Regina Au is Principal, New Product Planning at BioMarketing Insight with 20+ years experience in the biotechnology, pharmaceutical, medical device, diagnostic and healthcare industries. She helps companies to maximize the benefits of their technology by conducting the business due diligence early in product development to de-risk the process and increase commercial success. She will translate these unmet needs into a target product profile (TPP). Ms. Au then develops marketing strategies to ensure market access and product adoption.
Regina is a member of the Editorial Board for the International Journal of Clinical Pharmacology & Pharmacotherapy and Industry Advisor for the European BioPharmaceutical Review Journal. She has published numerous articles on market and technology trends such as "Immuno-oncology: Chimeric Antigen Receptors T-Cell Design; Microbiome; Genetic and Genomic Engineering; and Alzheimer Pathology. Her expertise is in a number therapeutic areas such as cardiology, interventional cardiology, infectious disease, immunology, gastroenterology, neurology, oncology and surgery.
She also serves as an advisor for the Massachusetts Technology Transfer Center Platform Meetings for entrepreneurs, Advisory Board member for a Delta V team at the Martin Trust Center for Entrepreneurship at MIT, and as a mentor for the MIT Enterprise Forum Mentoring Program.
Regina was a member of the Advisory Board for Regis College, Master of Regulatory and Clinical Research Management Program. She was also an Adjunct Professor at Northeastern University in the Masters in Biotechnology Program and at Regis College in the Master of Regulatory and Clinical Research Management Program.
Prior to BioMarketing Insight she worked for Merck & Co., Genzyme Corp., NMT Medical, and Radi Medical (St. Jude Medical) in various positions of increasing responsibility in new product planning, marketing and sales. She had P&L responsibility in managing six multimillion dollar product lines and has experience in upstream and downstream marketing including strategic marketing, product development, market development, product launches, and product management.